Silence Therapeutics (SLN) Asset Utilization Ratio (2021 - 2026)
Silence Therapeutics recorded quarterly Asset Utilization Ratio of 0.01 in Q1 2026, up 71.9% quarter-over-quarter from 0.0 in Q4 2025, and down 95.37% year-over-year from 0.14 in Q1 2025.
Silence Therapeutics' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.01 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 95.37% year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (down 95.37% YoY), while the FY2025 annual figure was 0.0, down 98.75% from the prior year.
- Asset Utilization Ratio came in at 0.01 for Q1 2026 at Silence Therapeutics, up from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.17 in Q3 2025 to a low of 0.0 in Q4 2025.
- A 5-year average of 0.07 and a median of 0.06 in 2024 frame the typical range for Asset Utilization Ratio.
- On a YoY basis, Asset Utilization Ratio climbed as much as 522.11% in 2025 and fell as far as 95.45% in 2025.
- Silence Therapeutics' Asset Utilization Ratio stood at 0.04 in 2022, then jumped by 49.6% to 0.07 in 2023, then grew by 28.24% to 0.08 in 2024, then slumped by 95.45% to 0.0 in 2025, then surged by 71.9% to 0.01 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.0, and 0.17 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.17 |
| Jun 30, 2025 | 0.15 |
| Mar 31, 2025 | 0.14 |
| Dec 31, 2024 | 0.08 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.07 |
| Sep 30, 2023 | 0.07 |
| Jun 30, 2023 | 0.07 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.05 |